What is the domestic price of ivonib (ivitinib)?

Ivosidenib (Ivosidenib), an innovative targeted anti-cancer drug, brings new treatment hope to leukemia patients. As the first IDH1 inhibitor, ivonib acts precisely on IDH1 gene mutations to inhibit the production of abnormal proteins, thereby interfering with the growth and division of leukemia cells. This unique mechanism of action makes ivosidenib excellent in the treatment of acute myeloid leukemia (AML) and its specific subtypes. Especially in patients with IDH1 gene mutations, the clinical effect of ivosidenib is particularly significant.

Since its introduction, ivosidenib has received widespread attention due to its significant therapeutic effect and safety. It has been approved by the U.S. FDA for the treatment of adults with relapsed or refractory AML, as well as newly diagnosed AML patients with susceptible IDH1 mutations. In addition, ivonib also shows potential application prospects in the treatment of cholangiocarcinoma, providing new treatment options for more patients.

Although ivonib has shown strong potential in treating cancer, patients still need to be aware of possible side effects during use. Common side effects include nausea, diarrhea, fatigue, etc., and some patients may also experience heart-related symptoms such as electrocardiogramQT prolongation. Therefore, when using ivonib, patients should undergo regular physical examinations and electrocardiogram monitoring to ensure the safety and effectiveness of the drug.

Avosidenib is currently on the market in China, but has not yet become part of the medical insurance reimbursement program. Avosidenib sold in China is the original research version, with the specification of 250mg*60 tablets, and the price is close to 90,000, which is relatively expensive. Patients may consider understanding the situation of ivonib in overseas markets. It is understood that Avonib in overseas markets is divided into original research and imitation. The price of the original research version is as high as 260,000 yuan, while the price of the imitation version on the market in Lucius, Laos is only about 6,800 yuan. For any questions about ivonib, it is recommended to consult a professional overseas medical consultant.

In short, as an innovative targeted anti-cancer drug, ivonib provides new treatment hope for patients with leukemia and other cancers. With the continuous deepening of research on ivonib and the continuous expansion of clinical applications, I believe it will bring good news to more patients.